Multiple reviewers describe starting at very low doses (0.04 ml) and taking months to reach therapeutic levels, all while being charged $199-299/mo
L., Guo, M., Chakravarthy, A., Medina, T
In clinical trials of the Wegovy pill, people titrating to a dose of 25 mg of oral semaglutide had about 6% weight loss (nearly 14 pounds) after 3 months
Als Triple-Agonist hat Retatrutid ein breiteres Nebenwirkungsprofil als reine GLP-1-Agonisten
Lastly, the $700 billion in market capitalization gains by Novo Nordisk and Eli Lilly since the launch of GLP-1 therapies is a stark indicator of financialization, as these valuations far exceed the cumulative revenue generated by the drugs themselves